138 related articles for article (PubMed ID: 20944091)
1. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
Kirschner K; Melton DW
Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
[TBL] [Abstract][Full Text] [Related]
2. Function and Interactions of ERCC1-XPF in DNA Damage Response.
Faridounnia M; Folkers GE; Boelens R
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563071
[TBL] [Abstract][Full Text] [Related]
3. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.
Niedernhofer LJ; Odijk H; Budzowska M; van Drunen E; Maas A; Theil AF; de Wit J; Jaspers NG; Beverloo HB; Hoeijmakers JH; Kanaar R
Mol Cell Biol; 2004 Jul; 24(13):5776-87. PubMed ID: 15199134
[TBL] [Abstract][Full Text] [Related]
4. XPF-ERCC1 protects liver, kidney and blood homeostasis outside the canonical excision repair pathways.
Mulderrig L; Garaycoechea JI
PLoS Genet; 2020 Apr; 16(4):e1008555. PubMed ID: 32271760
[TBL] [Abstract][Full Text] [Related]
5. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
Sabatella M; Theil AF; Ribeiro-Silva C; Slyskova J; Thijssen K; Voskamp C; Lans H; Vermeulen W
Nucleic Acids Res; 2018 Oct; 46(18):9563-9577. PubMed ID: 30165384
[TBL] [Abstract][Full Text] [Related]
6. Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation.
Jones M; Beuron F; Borg A; Nans A; Earl CP; Briggs DC; Snijders AP; Bowles M; Morris EP; Linch M; McDonald NQ
Nat Commun; 2020 Feb; 11(1):1120. PubMed ID: 32111838
[TBL] [Abstract][Full Text] [Related]
7. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
De Silva IU; McHugh PJ; Clingen PH; Hartley JA
Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1.
Tsodikov OV; Enzlin JH; Schärer OD; Ellenberger T
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11236-41. PubMed ID: 16076955
[TBL] [Abstract][Full Text] [Related]
9. Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
Wang AT; Sengerová B; Cattell E; Inagawa T; Hartley JM; Kiakos K; Burgess-Brown NA; Swift LP; Enzlin JH; Schofield CJ; Gileadi O; Hartley JA; McHugh PJ
Genes Dev; 2011 Sep; 25(17):1859-70. PubMed ID: 21896658
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.
Matoka DJ; Yao V; Harya DS; Gregg JL; Robinson AR; Niedernhofer LJ; Parwani AV; Maier C; Bacich DJ
Prostate; 2012 Aug; 72(11):1214-22. PubMed ID: 22212909
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.
Yang Z; Fang X; Pei X; Li H
Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490
[TBL] [Abstract][Full Text] [Related]
12. The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links.
Al-Minawi AZ; Lee YF; Håkansson D; Johansson F; Lundin C; Saleh-Gohari N; Schultz N; Jenssen D; Bryant HE; Meuth M; Hinz JM; Helleday T
Nucleic Acids Res; 2009 Oct; 37(19):6400-13. PubMed ID: 19713438
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
[TBL] [Abstract][Full Text] [Related]
14. The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif.
Enzlin JH; Schärer OD
EMBO J; 2002 Apr; 21(8):2045-53. PubMed ID: 11953324
[TBL] [Abstract][Full Text] [Related]
15. Role of the nucleotide excision repair gene ERCC1 in formation of recombination-dependent rearrangements in mammalian cells.
Sargent RG; Meservy JL; Perkins BD; Kilburn AE; Intody Z; Adair GM; Nairn RS; Wilson JH
Nucleic Acids Res; 2000 Oct; 28(19):3771-8. PubMed ID: 11000269
[TBL] [Abstract][Full Text] [Related]
16. Regulation of endonuclease activity in human nucleotide excision repair.
Fagbemi AF; Orelli B; Schärer OD
DNA Repair (Amst); 2011 Jul; 10(7):722-9. PubMed ID: 21592868
[TBL] [Abstract][Full Text] [Related]
17. The structure-specific endonuclease complex SLX4-XPF regulates Tus-Ter-induced homologous recombination.
Elango R; Panday A; Lach FP; Willis NA; Nicholson K; Duffey EE; Smogorzewska A; Scully R
Nat Struct Mol Biol; 2022 Aug; 29(8):801-812. PubMed ID: 35941380
[TBL] [Abstract][Full Text] [Related]
18. Structure of an XPF endonuclease with and without DNA suggests a model for substrate recognition.
Newman M; Murray-Rust J; Lally J; Rudolf J; Fadden A; Knowles PP; White MF; McDonald NQ
EMBO J; 2005 Mar; 24(5):895-905. PubMed ID: 15719018
[TBL] [Abstract][Full Text] [Related]
19. ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.
Heyza JR; Ekinci E; Lindquist J; Lei W; Yunker C; Vinothkumar V; Rowbotham R; Polin L; Snider NG; Van Buren E; Watza D; Back JB; Chen W; Mamdani H; Schwartz AG; Turchi JJ; Bepler G; Patrick SM
NAR Cancer; 2023 Mar; 5(1):zcac045. PubMed ID: 36644397
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer.
Liu J; Zhang L; Mao P; Jiang G; Liu L; Wang J; Yang W; Owusu L; Li W
Oncotarget; 2017 Oct; 8(49):85759-85771. PubMed ID: 29156754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
